Who are Fibrin Sealant (Artiss)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): TISSEEL VH fibrin sealant, TachoSil, Tisseel Fibrin Sealant, Bioseal Fibrin Sealant, Usage of Fibrin sealant, Fibrin sealant (FS2).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fibrin-sealant-artiss.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Fibrin Sealant (Artiss) — Competitive Intelligence Brief

Fibrin Sealant (Artiss) (Fibrin Sealant (Artiss)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fibrin sealant. Area: Surgery/Hemostasis.

marketed Fibrin sealant Fibrinogen; thrombin substrate Surgery/Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Fibrin Sealant (Artiss) (Fibrin Sealant (Artiss)) — Nguyen, Davis B., M.D.. Fibrin Sealant (Artiss) forms a fibrin clot by combining thrombin and fibrinogen to achieve hemostasis and tissue adhesion.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Fibrin Sealant (Artiss) TARGET	Fibrin Sealant (Artiss)	Nguyen, Davis B., M.D.	marketed	Fibrin sealant	Fibrinogen; thrombin substrate
TISSEEL VH fibrin sealant	TISSEEL VH fibrin sealant	Baxter Healthcare Corporation	phase 3	Fibrin sealant	Fibrinogen; Thrombin substrate
TachoSil	TachoSil	GATT Technologies BV	marketed	Hemostatic agent / Fibrin sealant	Fibrinogen (conversion to fibrin via thrombin)
Tisseel Fibrin Sealant	Tisseel Fibrin Sealant	Massachusetts General Hospital	marketed	Fibrin sealant	Fibrinogen (substrate for thrombin-catalyzed polymerization)
Bioseal Fibrin Sealant	Bioseal Fibrin Sealant	Ethicon, Inc.	marketed	Fibrin sealant / Hemostatic agent
Usage of Fibrin sealant	Usage of Fibrin sealant	Samsung Medical Center	phase 3	Hemostatic agent / Fibrin sealant	Fibrinogen / Factor XIII
Fibrin sealant (FS2)	Fibrin sealant (FS2)	Ethicon, Inc.	phase 3	Hemostatic agent / Fibrin sealant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fibrin sealant class)

Baxter Healthcare Corporation · 2 drugs in this class
Massachusetts General Hospital · 1 drug in this class
Nguyen, Davis B., M.D. · 1 drug in this class
Nycomed · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fibrin Sealant (Artiss) — Competitive Intelligence Brief. https://druglandscape.com/ci/fibrin-sealant-artiss. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab